Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Affective Disorders
- Vol. 83 (2-3) , 263-275
- https://doi.org/10.1016/j.jad.2004.05.008
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Treatment of Schizophrenia With Long-Acting Injectable RisperidoneThe Journal of Clinical Psychiatry, 2003
- Olanzapine Versus Divalproex Sodium for the Treatment of Acute Mania and Maintenance of Remission: A 47-Week StudyAmerican Journal of Psychiatry, 2003
- Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and SafetyAmerican Journal of Psychiatry, 2002
- Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?American Journal of Psychiatry, 2002
- Injections of Depot Antipsychotic Medications in Patients Suffering From SchizophreniaThe Journal of Clinical Psychiatry, 2001
- Risperidone Safety and Efficacy in the Treatment of Bipolar and Schizoaffective DisordersThe Journal of Clinical Psychiatry, 2001
- A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective DisorderAmerican Journal of Psychiatry, 2001
- Depot Antipsychotic DrugsDrugs, 1994
- Subjective response to neuroleptics and the quality of life: implications for treatment outcomeActa Psychiatrica Scandinavica, 1994
- II. the Incidence of Compliance Problems, Side-effects, Neurotic Symptoms and DepressionThe British Journal of Psychiatry, 1985